BDSX — Biodesix Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapSucker Stock
- $95.16m
- $91.94m
- $54.51m
Annual balance sheet for Biodesix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 5.91 | 5.29 | 62.1 | 32.7 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 1.89 | 5.29 | 15.3 | 3.66 |
| Total Other Current Assets | ||||
| Total Current Assets | 9.91 | 12.7 | 86.1 | 43.6 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 1.39 | 2.12 | 3.18 | 4.18 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | 39.1 | 41.6 | 121 | 76.1 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 4.47 | 22.6 | 32.1 | 29 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 53.1 | 76.2 | 79.9 | 56.4 |
| Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | -14.1 | -34.6 | 41.2 | 19.7 |
| Total Liabilities & Shareholders' Equity | 39.1 | 41.6 | 121 | 76.1 |
| Total Common Shares Outstanding |